Color vision and neuroretinal function in diabetes

Documenta Ophthalmologica

Volumn 130, Issue 2, 2015, Pages 131-139

  Wolff, B E ^a   Bearse, M A ^a   Schneck, M E ^a   Dhamdhere, K ^a   Harrison, W W ^b   Barez, S ^a   Adams, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Adams desaturated D 15; Color vision; Diabetes; Diabetic retinopathy; mfERG; Multifocal

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; COLOR CONFUSION SCORE; COLOR VISION; COLOR VISION DEFECT; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; AGED; COLOR VISION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; RETINA; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINA;

EID: 84924214998     PISSN: 00124486     EISSN: 15732622     Source Type: Journal    
DOI: 10.1007/s10633-014-9476-4     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta
2. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R (2010) Prevalence of diabetic retinopathy in the United States, 2005–2008. J Am Med Assoc (JAMA) 304(6):649–656. doi:10.1001/jama.2010.1111
3. American Diabetes Association (2013) The cost of diabetes. http://www.diabetes.org/advocate/resources/cost-of-diabetes.html. Accessed 12 Feb 2014
4. Ng JS (2009) Specific medical intervention for diabetic retinopathy. Med Hypotheses 73(2):158–160. doi:10.1016/j.mehy.2009.02.030
5. Zhang X, Wang N, Barile GR, Bao S, Gillies M (2013) Diabetic retinopathy: neuron protection as a therapeutic target. Int J Biochem Cell Biol 45(7):1525–1529. doi:10.1016/j.biocel.2013.03.002
6. Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366(13):1227–1239. doi:10.1056/NEJMra1005073
7. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52(2):1156–1163. doi:10.1167/iovs.10-6293
8. Pritchard N, Edwards K, Shahidi AM, Sampson GP, Russell AW, Malik RA, Efron N (2011) Corneal markers of diabetic neuropathy. Ocul Surf 9(1):17–28
9. Ziegler D, Papanas N, Zhivov A, Allgeier S, Winter K, Ziegler I, Bruggemann J, Strom A, Peschel S, Kohler B, Stachs O, Guthoff RF, Roden M (2014) Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 63(7):2454–2463. doi:10.2337/db13-1819
10. Bitirgen G, Ozkagnici A, Malik RA, Kerimoglu H (2014) Corneal nerve fibre damage precedes diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetic Med J Br Diabetic Assoc 31(4):431–438. doi:10.1111/dme.12324
11. Adams AJ, Haegerstrom-Portnoy G (1987) Color Deficiency. In: Amos JF (ed) Diagnosis and management in vision care, vol 1. Butterworth-Heinemann, Stoneham, pp 671–709
12. Bearse MA Jr, Adams AJ, Han Y, Schneck ME, Ng J, Bronson-Castain K, Barez S (2006) A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res 25(5):425–448. doi:10.1016/j.preteyeres.2006.07.001
13. Dhamdhere KP, Bearse MA Jr, Wolff BE, Harrison WW, Cardenas M, Barez S, Schneck ME, Adams AJ (2011) Associations between contrast sensitivity and multifocal electroretinograms in Type2 diabetes. Paper presented at the ARVO, Fort Lauderdale, Florida, 05/02/2011
14. Ewing FM, Deary IJ, Strachan MW, Frier BM (1998) Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev 19(4):462–476
15. Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF, Ventura DF (2010) Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge colour test. Ophthalmic Physiol Opt 30(5):717–723. doi:10.1111/j.1475-1313.2010.00776.x
16. Peduzzi M, Longanesi L, Ascari A, Cascione S, Galletti M, Roncaia R, Pacchioni C, Maione M (1989) Screening of early color vision loss in diabetic patients. J Fr Ophtalmol 12(11):791–796
17. Rodgers M, Hodges R, Hawkins J, Hollingworth W, Duffy S, McKibbin M, Mansfield M, Harbord R, Sterne J, Glasziou P, Whiting P, Westwood M (2009) Colour vision testing for diabetic retinopathy: a systematic review of diagnostic accuracy and economic evaluation. Health Technol Assess 13(60):1–160. doi:10.3310/hta13600
18. Sukha AY, Rubin A (2009) High, medium, and low contrast visual acuities in diabetic retinal disease. Optom Vis Sci Off Publ Am Acad Optom 86(9):1086–1095. doi:10.1097/OPX.0b013e3181b48635
19. Wolff BE, Bearse MA Jr, Schneck ME, Barez S, Adams AJ (2010) Multifocal VEP (mfVEP) reveals abnormal neuronal delays in diabetes. Doc Ophthalmol Adv Ophthalmol 121(3):189–196. doi:10.1007/s10633-010-9245-y
20. Adams AJ et al (1982) Chromaticity and luminosity changes in glaucoma and diabetes. Doc Ophthalmol Proc Ser 33:413–418
21. Barca L, Vaccari G (1977) On the impairment of color discrimination in diabetic retinopathy, a report of 24 cases. Atti Fond G Ronchi 32:635–640
22. Birch JM, Chisholm I, Kinnear P, Marre M, Pinckers AJLG, Pokorny J, Smith VC, Verriest G (1979) Acquired color vision defects. In: Pokory J, Smith VC, Verriest G, Pinckers AJLG (eds) Congenital and Acquired Color Vision Defects. Grune and Stratton Inc, New York, pp 282–284
23. Kinnear PR, Aspinall PA, Lakowski R (1972) The diabetic eye and colour vision. Trans Ophthalmol Soc U K 92:69–78
24. Lakowski R, Aspinall PA, Kinnear PR (1973) Association between colour vision losses and diabetes melitus. Ophthalmic Res 4:145–159
25. Verriest G (1964) Acquired Color Perception Defects. Memoires de l’Academie royale de medecine de Belgique 18:35–327
26. Zanen J (1953) [Introduction to the study of acquired central retinal dyschromatopsias]. Bull Soc Belge Ophtalmol 103:3–144; discussion, 144–148
27. Zanen J, Szucs S, Pirart J (1957) Achromatic & chromatic thresholds in diabetes. Bull Soc Belge Ophtalmol 115(Pt 2):210–219
28. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ (2004) Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci 45(3):948–954
29. Harrison WW, Bearse MA Jr, Ng JS, Jewell NP, Barez S, Burger D, Schneck ME, Adams AJ (2011) Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 52(2):772–777. doi:10.1167/iovs.10-5931
30. Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ (2008) Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 49(4):1622–1628. doi:10.1167/iovs.07-1157
31. Harrison WW, Bearse MA Jr, Schneck ME, Wolff BE, Jewell NP, Barez S, Mick AB, Dolan BJ, Adams AJ (2011) Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 52(9):6825–6831. doi:10.1167/iovs.11-7533
32. Bresnick GH, Condit RS, Palta M, Korth K, Groo A, Syrjala S (1985) Association of hue discrimination loss and diabetic retinopathy. Arch Ophthalmol 103(9):1317–1324
33. Adams AJ, Rodic R, Husted R, Stamper R (1982) Spectral sensitivity and color discrimination changes in glaucoma and glaucoma-suspect patients. Invest Ophthalmol Vis Sci 23(4):516–524
34. Hovis JK, Ramaswamy S, Anderson M (2004) Repeatability indices for the Adams D-15 test for colour-normal and colour-defective adults. Clin Exp Optom J Aust Optom Assoc 87(4–5):326–333
35. Adams AJ, Rodic R (1982) Use of desaturated and saturated versions of the D-15 test in glaucoma and glaucoma-suspect patients. In: Verriest G (ed) Colour vision deficiencies IV. Doc Ophthalmol Proc Series, vol 33. The Hague: Dr W Junk, pp 419–424
36. Vingrys AJ, King-Smith PE (1988) A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci 29(1):50–63
37. Hood DCLJ (1997) A technique for measuring individual multifocal ERG records: non-invasive assessment of the visual system. Trends Opt Photon 11:33–41
38. Fortune B, Schneck ME, Adams AJ (1999) Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci 40(11):2638–2651
39. Han Y, Adams AJ, Bearse MA Jr, Schneck ME (2004) Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 122(12):1809–1815. doi:10.1001/archopht.122.12.1809
40. Hardy KJ, Fisher C, Heath P, Foster DH, Scarpello JH (1995) Comparison of colour discrimination and electroretinography in evaluation of visual pathway dysfunction in aretinopathic IDDM patients. Br J Ophthalmol 79(1):35–37
41. Arden GB, Wolf JE (2004) Colour vision testing as an aid to diagnosis and management of age related maculopathy. Br J Ophthalmol 88(9):1180–1185. doi:10.1136/bjo.2003.033480
42. Berninger T, Drobner B, Hogg C, Rudolph G, Arden GB, Kampik A (1999) Color vision in relation to age: a study of normal values. Klin Monatsbl Augenheilkd 215(1):37–42. doi:10.1055/s-2008-1034667
43. Roy MS, Podgor MJ, Collier B, Gunkel RD (1991) Color vision and age in a normal North American population. Graefe’s Arch Clin Exp Ophthalmol (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 229(2):139–144
44. Nguyen-Tri D, Overbury O, Faubert J (2003) The role of lenticular senescence in age-related color vision changes. Invest Ophthalmol Vis Sci 44(8):3698–3704